SEC Form 4 · accession 0001209191-19-001488
IRONWOOD PHARMACEUTICALS INC · IRWD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Terrance McGuire
Director
Period of report
Dec 31, 2018
Accepted (ET)
Jan 3, 2019 · 7:58 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001446847
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class B Common StockF1,F2 | Dec 31, 2018 | J | 40,000 | — | D | 0 | I | By Bartlett Partners, LLC |
| Class A Common StockF1,F2 | Dec 31, 2018 | J | 40,000 | — | A | 69,117 | I | By Bartlett Partners, LLC |
| Class A Common StockF3 | holding | — | — | — | 1,626 | I | By Polaris Venture Management Co., II L.L.C | |
| Class A Common Stock | holding | — | — | — | 77,503 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On December 31, 2018, each share of the Issuer's outstanding Class B Common Stock automatically converted into one share of the Issuer's Class A Common Stock pursuant to the Issuer's certificate of incorporation.
- F2The reporting person is a managing member of Bartlett Partners, LLC, the beneficial owner of the securities. The reporting person disclaims beneficial ownership of the securities, except to the extent of his pecuniary interest therein.
- F3The reporting person is a managing member of Polaris Venture Management Co. II, L.L.C., the beneficial owner of the securities. The reporting person disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interest therein.